Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
abx411417-1ml |
Abbexa |
1 ml |
EUR 610.8 |
|
Human IgG antibody Laboratories manufactures the spike glycoprotein gp120 reagents distributed by Genprice. The Spike Glycoprotein Gp120 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact . Other Spike products are available in stock. Specificity: Spike Category: Glycoprotein Group: Gp120
gp120 Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
gp120 Antibody |
SAB |
100ul |
EUR 479 |
gp120 Antibody |
SAB |
100ul |
EUR 468 |
gp120 Antibody |
SAB |
100ul |
EUR 479 |
gp120 Antibody |
SAB |
100ul |
EUR 468 |
gp120 Antibody |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
gp120 Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
Gp120 information
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
abx411417-1ml |
Abbexa |
1 ml |
EUR 610.8 |
|
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
abx412175-1mg |
Abbexa |
1 mg |
EUR 610.8 |
|
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
abx411417-100tests |
Abbexa |
100 tests |
EUR 425 |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
abx412175-100g |
Abbexa |
100 µg |
EUR 425 |
COVID-19 Spike glycoprotein Antibody |
E38PA9966 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
COVID-19 Spike glycoprotein Antibody |
MBS8584658-01mL |
MyBiosource |
0.1mL |
EUR 305 |
COVID-19 Spike glycoprotein Antibody |
MBS8584658-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
COVID-19 Spike glycoprotein Antibody |
MBS8584658-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
COVID-19 Spike glycoprotein Antibody |
MBS8584658-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
COVID-19 Spike glycoprotein Antibody |
MBS8584658-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
InVivoMAb Anti-HIV1 gp120/Glycoprotein 120 (Iv0038) |
MBS1570062-01mg |
MyBiosource |
0.1mg |
EUR 405 |
InVivoMAb Anti-HIV1 gp120/Glycoprotein 120 (Iv0038) |
MBS1570062-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1520 |
Bovine coronavirus Spike glycoprotein (S) |
1-CSB-YP333052BJO |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S),partial expressed in Yeast |
Bovine coronavirus Spike glycoprotein (S) |
1-CSB-EP322803BJK |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S),partial expressed in E.coli |
Bovine coronavirus Spike glycoprotein (S) |
1-CSB-EP333052BJO |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Bovine coronavirus Spike glycoprotein(S) ,partial expressed in E.coli |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (HRP) |
abx411419-1ml |
Abbexa |
1 ml |
EUR 760.8 |
|
Recombinant Spike glycoprotein (G), partial |
MBS1076910-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |